Latest Articles about ANGO

Bearish MACD for AngioDynamics, Inc. - Tale of the Tape

Zacks Equity Research — Thu, 25 Apr 2013 19:13:03 Z

AngioDynamics, Inc. 's ( ANGO ) MACD indicator has moved into bearish territory with a reading of -0.3847. The Zacks Rank #4 ("Sell") stock decreased more than 0.10% to $10.16

Company News for April 10, 2013 - Corporate Summary

Zacks Equity Research — Wed, 10 Apr 2013 18:36:01 Z

• Schulman Inc. (NASDAQ: SHLM ) posted second quarter earnings per share of $0.27, falling shy of the Zacks Consensus Estimate of $0.40 • Mistras

Benzinga Market Primer: Tuesday, April 9

Matthew Kanterman — Tue, 09 Apr 2013 14:43:40 Z

Futures Rise On Alcoa Beat U.S. equity futures rose slightly in pre-market trade following a positive report from economic bellwether Alcoa (NYSE: AA ). Alcoa reported first quarter EPS

After-Hours Earnings Report for April 8, 2013 : AA, SHLM, MG, ANGO

NASDAQ.com News — Mon, 08 Apr 2013 22:00:04 Z

The following companies are expected to report earnings after hours on 04/08/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Alcoa Inc. ( AA ) is reporting

The Barclays Triggers More Insider Buying

Monica Wolfe — Thu, 14 Mar 2013 03:09:51 Z

The Barclays Global Healthcare Conference seems to have triggered a trend within insider trading in the medicine and healthcare industries. Earlier we saw five insider buys the day before

Angio Posts Dismal Prelim Results - Analyst Blog

Zacks Equity Research — Fri, 08 Mar 2013 23:50:01 Z

AngioDynamics Inc. ( ANGO ), a provider of therapeutic and diagnostic devices for the treatment of peripheral vascular and other non-coronary diseases, has released its preliminary

Angio Closes Microsulis Deal - Analyst Blog

Zacks Equity Research — Mon, 04 Feb 2013 20:00:01 Z

AngioDynamics Inc. ( ANGO ), a provider of therapeutic and diagnostic devices for the treatment of peripheral vascular and other non-coronary diseases, completed its previously announced

ANGO and Microsulis Work Out Deal - Analyst Blog

Zacks Equity Research — Fri, 25 Jan 2013 01:00:01 Z

Consolidating its earlier partnership, AngioDynamics ( ANGO ) inked a definitive agreement to purchase certain assets of Mircosulis Medical Ltd. The transaction is expected to close this

ANGO Beats on EPS, Tweaks View - Analyst Blog

Zacks Equity Research — Fri, 04 Jan 2013 18:28:01 Z

AngioDynamics Inc. ( ANGO ) reported adjusted earnings of 10 cents per share for the second quarter of fiscal 2013 ended November 30, 2012, beating the Zacks Consensus Estimate by a penny

After-Hours Earnings Report for January 3, 2013 : PRGS, SHLM, SONC, ANGO, FC

NASDAQ.com News — Fri, 04 Jan 2013 00:00:03 Z

The following companies are expected to report earnings after hours on 01/03/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Progress Software Corporation (

CR Bard Remains Neutral - Analyst Blog

Zacks Equity Research — Thu, 06 Dec 2012 21:40:01 Z

We have reiterated our Neutral rating on CR Bard Inc. ( BCR ) following its third quarter results with a price target of $103. In the reported quarter, adjusted earnings of $1.64 per share

AngioDynamics Closes Vortex Buyout - Analyst Blog

Zacks Equity Research — Thu, 18 Oct 2012 01:45:01 Z

Provider of therapeutic and diagnostic devices to treat peripheral vascular and other non-coronary diseases, AngioDynamics ( ANGO ) has completed its previously announced acquisition of

AngioDynamics Wins GPO Contract - Analyst Blog

Zacks Equity Research — Thu, 11 Oct 2012 18:30:01 Z

Therapeutic and diagnostic devices maker AngioDynamics ( ANGO ) recently won a contract with HealthTrust Purchasing Group, a group purchasing organization ("GPO") that supports

AngioDynamics to Buy Vortex - Analyst Blog

Zacks Equity Research — Thu, 11 Oct 2012 01:51:27 Z

Recently, AngioDynamics ( ANGO ) inked a definitive agreement to acquire the outstanding capital stock of privately-owned Vortex Medical Inc. for $15 million in cash. The acquisition is

Mixed 1Q13 for AngioDynamics - Analyst Blog

Zacks Equity Research — Tue, 09 Oct 2012 19:59:01 Z

AngioDynamics Inc. ( ANGO ) reported first-quarter fiscal 2013 (ended August 31) adjusted earnings of 10 cents per share, beating the Zacks Consensus Estimate by a penny. The year-ago